Rigontec Overview
- Founded
- 2014

- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Latest Deal Amount
- $551M

Rigontec General Information
Description
Developer of RNA-based immunotherapeutics for cancer and viral diseases intended to harness one of the most essential pathways in the innate immune system. The company's RNA-based immunotherapeutics offers proprietary retinoic acid inducible gene I (RIG-I) activators for the treatment of cancer and is designed to initiate specific activation of multiple RIG-I pathways to kill tumor cells and to enable long-term immunity against the cancer associated with the tumor, enabling healthcare providers to generate effective therapies.
Contact Information
- Izb, Am Klopferspitz 19
- Planegg/Martinsried
- 82152 Munich
- Germany
Rigontec Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 26-Oct-2017 | $551M | 000.00 | 00000 | Completed | Generating Revenue |
2. Early Stage VC (Series A) | 06-Sep-2016 | 000.00 | 000.00 | Completed | Startup | |
1. Accelerator/Incubator | Completed | Startup |
Rigontec Comparisons
Industry
000000
0000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialRigontec Competitors (38)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Gadeta | Venture Capital-Backed | Utrecht, Netherlands | 00 | 00.000 | 000000000000 | 00.000 |
0000000 0000000000 | Venture Capital-Backed | Philadelphia, PA | 00 | 00000 | 00000000000 | 00000 |
0000 00000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
000000000000 | Venture Capital-Backed | Seattle, WA | 00 | 000.00 | 00000000000 | 000.00 |
000000000 00000000 | Venture Capital-Backed | Rockville, MD | 0 | 000.00 | 0000000000 0 | 000.00 |
Rigontec Former Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Boehringer Ingelheim Venture Fund | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
FORBION | Venture Capital | Minority | 000 0000 | 000000 0 | |
German Accelerator | Accelerator/Incubator | 000 0000 | 000000 0 | ||
High-Tech Gründerfonds | Venture Capital | Minority | 000 0000 | 000000 0 | |
MP Healthcare Venture Management | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |